Atrial Fibrillation Trial, Recruiting NCT06523738 Sponsor: The Second Affiliated Hospital of Chongqing Medical University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06523738
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that continues for a long period) within the past 6 months
  • People whose left atrial diameter (a measurement of one of the heart's chambers) was between 40mm and 50mm before entering the study
  • People who have already had a successful cardioversion, which is a procedure — either using medication or an electrical shock — that was used to restore a normal heart rhythm
  • People who have had at least two heart ultrasound scans: one before cardioversion and one between 3 and 6 months after, confirming how the heart chamber has changed
  • People who have given their informed consent to take part in the trial

Who may not be able to join:

  • People who have previously had a radiofrequency ablation procedure to treat atrial fibrillation (a procedure that uses heat energy to destroy small areas of heart tissue causing abnormal rhythms)
  • People who have previously had heart surgery
  • People with cognitive impairments that prevent them from being able to give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613508335502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
1 July 2019
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Recurrence of atrial fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov